Amplimmune, Inc.

Amplimmune, Inc. is a biopharmaceutical company focused on developing novel cancer immunotherapies. With a pipeline of innovative therapeutics designed to harness the body's own immune system to fight cancer, Amplimmune is dedicated to improving outcomes for patients with various types of cancer. The company's research and development efforts are centered on advancing therapies that target immune checkpoints, with the goal of enabling the immune system to recognize and destroy cancer cells. Amplimmune is committed to advancing the field of immuno-oncology and making a meaningful impact on cancer treatment.